Editor

Spineology Secures $25 Million in Equity Financing to Accelerate Growth and Innovation

Spineology, a leader in Conform and Expand™ spinal fusion technology, has successfully closed a $25 million Series AA funding round. The investment was led by SV Health Investors, with additional contributions from 1315 Capital and existing investor RC Capital. This new funding is set to drive Spineology’s expansion in commercial growth, clinical education, and product…

Read More

Boostly Secures $5.6 Million Seed Funding to Transform Restaurant Marketing

In a significant move poised to revolutionize restaurant marketing, Boostly has announced the successful completion of a $5.6 million seed funding round. This investment was spearheaded by Trestle Partners and includes contributions from Relish Works, Singularity Capital, and Y Combinator. The funds are set to propel Boostly’s mission of equipping restaurants with cutting-edge tools to…

Read More
Ben Heinzelmann co-founder and CEO,

Energy Domain Secures $5 Million Series A Funding to Advance Oil and Gas Data Solutions

Energy Domain, the innovative tech-driven marketplace for oil and gas transactions, has successfully closed a $5 million Series A funding round. This investment will expedite the development of its upcoming data platform, Energy Domain Data, while enhancing its existing marketplace operations. The Series A round drew contributions from a broad spectrum of investors, including industry…

Read More

Avoli Celebrates First Year with Major Milestones: New Athletes, Retail Partnership, and $2.1M Funding Round

Avoli, the pioneering athletic brand dedicated to the performance needs of women and girl volleyball players, has marked its first anniversary with a series of significant achievements. The company announced the successful closure of its seed funding round, surpassing its initial target with $2.1 million raised. This funding round saw contributions from prominent figures in…

Read More
Steve Brierley, Riverlane Founder and CEO

Riverlane Secures $75 Million in Series C Funding to Accelerate Quantum Error Correction Technology

Riverlane, a leader in quantum error correction (QEC) technology, has announced a successful Series C funding round, raising $75 million to advance its pioneering QEC roadmap. The round was led by Planet First Partners, with participation from ETF Partners, EDBI, and existing investors Cambridge Innovation Capital (CIC), Amadeus Capital Partners, the UK’s National Security Strategic…

Read More
Rajiv Khemani, Co-founder and CEO of Aurascape AI,

Aurascape AI Raises $12.8 Million in Oversubscribed Seed Round to Revolutionize Cybersecurity for the AI Era

Aurascape AI, an innovative cybersecurity startup designed for the AI age, has successfully closed an oversubscribed $12.8 million seed funding round. The investment was led by Mayfield Fund, with additional support from Celesta Capital, StepStone Group, AISpace, and notable industry figures including Mark McLaughlin, former Chairman and CEO of Palo Alto Networks. Aurascape AI is…

Read More
Derek Stein Founder of Adept Materials

Adept Materials Secures $4M in Seed Funding to Revolutionize Building Moisture Control

Adept Materials, a trailblazer in advanced materials technology, has announced a significant milestone with the successful closing of its first $4 million seed funding round. This injection of capital is poised to accelerate the commercialization of Adept’s groundbreaking directional moisture control technology. The funding round is spearheaded by major North American homebuilders D.R. Horton and…

Read More

NeuroTherapia Gains $12.3M in Series B Funding to Advance Breakthrough Alzheimer’s Treatment

NeuroTherapia, Inc., a clinical-stage biotech company and Cleveland Clinic Innovations portfolio entity, has successfully completed the first close of its Series B financing with $12.3M raised. The financing round, led by Cleveland Clinic, sees continued support from Brain Trust Accelerator Fund II, Dolby Family Ventures, and the Alzheimer’s Drug Discovery Foundation (ADDF), with new investment…

Read More
Dan Kemp CEO at Shinobi Therapeutics

Shinobi Therapeutics Receives $59M Grant from Japanese Agency for Medical Research and Development

Shinobi Therapeutics, a trailblazer in immune evasive iPS cell therapies, has been awarded up to $59 million in non-dilutive grant funding by the Japanese Agency for Medical Research and Development (AMED). This significant grant will accelerate the development of Shinobi’s pioneering iPS-T cell therapy, aimed at treating GPC3+ solid tumors. Dr. Yasumichi Hitoshi, Chief of…

Read More

Inscora Secures $2 Million Funding to Revolutionize Cyber Insurance Brokerage

Inscora, an innovative Montreal-based startup specializing in automated cyber risk assessment and sales enablement for cyber insurance brokers, has successfully raised $2 million in its latest funding round. The investment, led by Luge Capital, includes contributions from Desjardins Capital, Accelia Capital, Inovia Capital, and notable angel investors from the cybersecurity sector. Founded by Gabriel Tremblay,…

Read More